首页> 外文会议>IEEE Portuguese Meeting in Bioengineering >Preparation and characterization of amylose-pyrazinamide inclusion complexes
【24h】

Preparation and characterization of amylose-pyrazinamide inclusion complexes

机译:直链淀粉-吡嗪酰胺包合物的制备与表征

获取原文

摘要

Amylose is a linear polymer composed almost entirely of α-1,4-linked units. This biopolymer tends to form single helical inclusion complexes with suitable agents. The study of these complexes presents a great interest since the guest molecules that have been trapped at some stage can be release later, thus leading to many applications, especially in the pharmaceutical and food industry. Amylose is considered as a promising carrier biomaterial of prodrugs [1]. Pyrazinamide (PZA) has long been recognized as an active drug against Mycobacterium tuberculosis, however the administration of PZA in high dosage can cause bacterial resistance. Therefore there is a need for new methodologies which would reduce the administration time and improve therapeutic effect of PZA [2]. The aim of our study was to characterize the amylose-PZA complex. The inclusion complex was prepared by acidification of an alkali solution. Formation and characterization (particle size) of the inclusion complexes in solution were characterized by dynamic light scattering and UV spectroscopy. As the complexation causes changes in the absorption spectrum of a guest molecule, change in the colour of the solution from yellow to colourless was noticed. Furthermore, differences in intensity of the bands, and a slight shift of the absorption spectrum of inclusion complexes, in comparison with the pure amylose solution were observed. The UV analyses confirmed the formation of the amylose-PZA inclusion complexes. DLS analysis has been made for: complexes with pure amylose (without PZA), with PZA (without amylose) and amylose-PZA complexes. The amylose particle size, without the guest molecule, was (101,16±2,60) nm and its relative average poly dispersity index was 0,41±0,04. For the PZA particle the size was (223,70±13,76) nm and its relative average polydispersity index was 0,27±0,10. On the other hand for the amylose-PZA inclusion complexes the size (81,11±1,43- nm was observed and its relative average polydispersity index was 0,26±0,02. As can be seen the size of the complex is smaller than of the pure amylose or PZA particle in solution. This can be attributed to the presence of PZA that induces hydrophobic interactions resulting in the contraction of the complexes and providing a relatively hydrophilic surface. Furthermore, PDI results also indicated that sizes generated from inclusion complexes have a narrow size distribution. Thus, new analysis tests will be conducted to provide more information about structure and morphology of inclusion complexes.
机译:直链淀粉是几乎完全由α-1,4-连接单元组成的线性聚合物。这种生物聚合物倾向于与合适的试剂形成单一的螺旋形包合物。这些复合物的研究引起了极大的兴趣,因为在某个阶段被捕获的客体分子可以稍后释放,从而导致许多应用,尤其是在制药和食品工业中。直链淀粉被认为是前药有前途的载体生物材料[1]。吡嗪酰胺(PZA)一直被认为是抗结核分枝杆菌的活性药物,但是高剂量的PZA给药会引起细菌耐药性。因此,需要一种新的方法来减少给药时间并改善PZA的治疗效果[2]。我们研究的目的是表征直链淀粉-PZA复合物。包合物通过碱溶液的酸化来制备。通过动态光散射和紫外光谱对溶液中包合物的形成和表征(粒径)进行了表征。由于络合作用引起客体分子吸收光谱的变化,因此注意到溶液的颜色从黄色变为无色。此外,与纯直链淀粉溶液相比,观察到了谱带强度的差异以及包合物的吸收光谱的微小变化。紫外线分析证实了直链淀粉-PZA包合物的形成。已对以下物质进行了DLS分析:具有纯直链淀粉(不含PZA),具有PZA(不含直链淀粉)和直链淀粉-PZA的复合物。没有客体分子的直链淀粉粒度为(101,16±2,60)nm,其相对平均多分散指数为0.41±0.04。对于PZA颗粒,其尺寸为(223,70±13,76)nm,其相对平均多分散指数为0.27±0.10。另一方面,对于直链淀粉-PZA包合物,观察到的大小为(81,11±1,43-nm),相对平均多分散指数为0.26±0.02。比溶液中的纯直链淀粉或PZA颗粒小,这可以归因于PZA的存在,该PZA引起疏水相互作用,导致复合物收缩并提供相对亲水的表面。配合物的尺寸分布较窄,因此,将进行新的分析测试,以提供更多有关夹杂物结构和形态的信息。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号